Walgreens offers consumers advice in case of evacuations
DEERFIELD, Ill. Walgreens has published a short list of suggestions for anyone in areas affected by potential hurricanes, such as Tropical Storm Hanna, which, at press time, was heading toward the Florida coast and threatening to develop into a hurricane.
While the advice was simple, it may make a big difference for prescription medication takers who have to be evacuated:
- Fill the medication only after arriving at a safe location.
- Carry the medication in a waterproof bag.
- Keep a written record of all prescriptions in an “important papers” file.
Walgreens emphasized in step 2 that all prescription bottles should be taken, even if empty. The information on the bottle label will help any pharmacist refill the medicine. Heat, humidity and sunlight can degrade the effectiveness of medicine, so Walgreens reminded consumers to protect it from extreme weather conditions.
The company also reminded consumers that Walgreens’ patients could register online at Walgreens.com and print out prescription information directly from their patient profile. Walgreens operates 6,356 drugstores in 49 states, the District of Columbia and Puerto Rico.
Teva’s Azilect slows Parkinson’s disease in trials
WASHINGTON Results from a Phase III clinical trial have shown that Teva Pharmaceutical’s Azilect 1-mg tablets can slow the progression of the disease, the drug maker announced.
Researchers gave 1,176 Parkinson’s disease patients daily 1- to 2-mg doses of Azilect for 18 months or a placebo for the first nine months and the drug for the second nine months.
Patients who took the 1-mg dose of Azilect showed significant improvement compared with patients in the placebo group.
The Food and Drug Administration approved Azilect in May 2006 as a monotherapy for early-stage ParkinsonOs disease and as an adjunct therapy to levodopa in moderate-to-advanced stages of the disease.
The drug, known generically as rasagiline mesylate, is available in 30 countries. Danish drug maker Lundbeck markets it in Europe, and both companies plan to co-promote it in the United Kingdom, Germany and France.
Taro to ask for extension on Sun Pharmaceuticals’ offer
TEL AVIV,, Israel Taro Pharmaceutical Industries has said it will appeal to Israel’s Supreme Court to contest a ruling in the Tel Aviv District Court regarding India-based Sun Pharmaceuticals’ offer to acquire the Israeli generic drug maker.
The District Court judge had called Taro’s demand for a tender offer from Sun disingenuous, considering Taro’s acceptance of the offer a year ago.
Taro plans to ask the Supreme Court to extend the deadline for Sun’s offer, which was Tuesday at 5 p.m.